DOCTORS

Your main goal is the health of your patient. You have invested your skill and time in elaborating an accurate and precise diagnosis, investigating the best pharmacological therapy. You are aware that when you have to prescribe treatment for your patient the active pharmaceutical ingredient (API) has direct pharmacological effect in the diagnosis, cure, mitigation, treatment or prevention of a disease.

Dipharma has 70 years’ experience in manufacturing high quality active pharmaceutical ingredients. In our three manufacturing facilities located in Europe, we apply current Good Manufacturing Practices to our manufacturing processes. They are clearly defined and controlled and, from raw material purchase to final product, we validate critical process steps impacting the quality and purity of the API.

You know that when you prescribe a product that contains Dipharma’s active pharmaceutical ingredient you are prescribing a quality product which has been manufactured in Europe under the strictest standards of purity and process control.

FAQ

What are the requirements for manufacturing active pharmaceutical ingredients?

The National Agencies of Health as the US Food and Drug Administration (FDA), expect Active Pharmaceutical Ingredient producers to apply Good Manufacturing Practices (cGMP) to the manufacturing process beginning with the use of starting materials and validate critical process steps that impact the quality and purity of the final API. Controls over material quality are expected to increase as the process approaches the final API.

What is meant by current good manufacturing practices?

Good Manufacturing Practice (GMP) is a system of production and testing practices implemented to ensure the quality of a product. Pharmaceutical firms and Active Pharmaceutical Ingredient producers apply the Current Good Manufacturing Practices in order to ensure that the products produced meet defined requirements for identity, strength, quality, and purity.